Trexquant Investment »

Compass Therapeutics shares owned by Trexquant Investment

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Trexquant Investment from 13F filings

Historical chart of Trexquant Investment investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Trexquant Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Trexquant Investment

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.2M 422k 5.29

More positions owned by Trexquant Investment

NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Micron Technology Call Option (MU)
Amazon Call Option (AMZN)
Tesla Motors Put Option (TSLA)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Citigroup Com New Put Option (C)
Palantir Technologies Cl A Put Option (PLTR)
Pepsi (PEP)
Accenture Plc Ireland Shs Class A Call Option (ACN)
Alphabet Cap Stk Cl C Call Option (GOOG)
Chipotle Mexican Grill (CMG)
Eli Lilly & Co. (LLY)

View all positions for Trexquant Investment

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Vivo Capital
BlackRock
Vanguard Group
Enavate Sciences GP
BVF
Vanguard Capital Management
State Street Corporation
Adage Capital Partners GP
Deerfield Management Company
Geode Capital Management
Blue Owl Capital Holdings
Rock Springs Capital Management

View all funds holding Compass Therapeutics